Stock Fundamentals

Company Information

Company Name
10X Genomics Inc
Sector
Healthcare
Industry
Health Information Services
Exchange
NASDAQ
ISIN: US88025U1097
CIK: 0001770787
CUSIP: 88025U109
Currency: USD
Full Time Employees: 1,178
Phone: 925 401 7300
Fiscal Year End: December
IPO Date: Sep 12, 2019
Description:

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Address:

6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Directors & Officers

Name Title Year Born
Dr. Serge Saxonov Ph.D. Co-Founder, CEO & Director 1977
Dr. Benjamin J. Hindson Ph.D. Co-Founder, President, Chief Scientific Officer & Director 1975
Mr. Adam S. Taich CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer 1975
Mr. Jim Goodrich Chief of Global Operations NA
Mr. Michael Schnall-Levin Ph.D. Founding Scientist & CTO NA
Ms. Cassie Corneau Manager of Investor Relations & Strategic Finance NA
Dr. Randy Wu General Counsel and Secretary NA
Ms. Mennah Moustafa Chief Commercial Officer NA
Mr. Jens Durruthy Associate Director of Product Management NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 13.02M Dec 31, 2025 10.19% $0.00 -1.93%
FMR Inc 11.92M Dec 31, 2025 9.33% $0.01 40.90%
ARK Investment Management LLC 11.89M Sep 30, 2025 9.31% $0.83 -14.43%
BlackRock Inc 9.46M Sep 30, 2025 7.41% $0.00 0.27%
Millennium Management LLC 5.44M Sep 30, 2025 4.26% $0.03 88.57%
Sumitomo Mitsui Trust Group Inc 5.38M Sep 30, 2025 4.21% $0.04 -10.58%
Amova Asset Management Americas, Inc 5.38M Sep 30, 2025 4.21% $0.61 -10.53%
Quantinno Capital Management LP 3.49M Sep 30, 2025 2.73% $0.11 56.37%
Bank of America Corp 3.41M Sep 30, 2025 2.67% $0.00 12.89%
Morgan Stanley - Brokerage Accounts 2.82M Sep 30, 2025 2.21% $0.00 -19.21%
AQR Capital Management LLC 2.73M Sep 30, 2025 2.13% $0.02 -34.10%
Geode Capital Management, LLC 2.71M Sep 30, 2025 2.12% $0.00 2.28%
The Goldman Sachs Group Inc 2.68M Sep 30, 2025 2.09% $0.00 340.19%
Jacobs Levy Equity Management, Inc. 2.64M Dec 31, 2025 2.07% $0.17 -10.45%
State Street Corp 2.52M Sep 30, 2025 1.97% $0.00 1.10%
JPMorgan Chase & Co 2.15M Sep 30, 2025 1.68% $0.00 1,655.11%
Renaissance Technologies Corp 1.55M Dec 31, 2025 1.21% $0.04 48.39%
Dimensional Fund Advisors, Inc. 1.52M Dec 31, 2025 1.19% $0.01 100.90%
Capital World Investors 1.45M Sep 30, 2025 1.14% $0.00 0.00%
Wellington Management Company LLP 1.45M Dec 31, 2025 1.13% $0.00 -66.19%

Shares Statistics

Shares Outstanding: 117.67M
Shares Float: 115.51M
% Insiders: 181.70%
% Institutions: 10,783.40%
Short % Float: 22.90%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 13.02M 10.19% ▼ 1.93% Dec 31, 2025
2 FMR Inc 11.92M 9.33% ▲ 40.90% Dec 31, 2025
3 ARK Investment Management LLC 11.89M 9.31% ▼ 14.43% Sep 30, 2025
4 BlackRock Inc 9.46M 7.41% ▲ 0.27% Sep 30, 2025
5 Millennium Management LLC 5.44M 4.26% ▲ 88.57% Sep 30, 2025
6 Sumitomo Mitsui Trust Group Inc 5.38M 4.21% ▼ 10.58% Sep 30, 2025
7 Amova Asset Management Americas, Inc 5.38M 4.21% ▼ 10.53% Sep 30, 2025
8 Quantinno Capital Management LP 3.49M 2.73% ▲ 56.37% Sep 30, 2025
9 Bank of America Corp 3.41M 2.67% ▲ 12.89% Sep 30, 2025
10 Morgan Stanley - Brokerage Accounts 2.82M 2.21% ▼ 19.21% Sep 30, 2025

Valuation Metrics

Enterprise Value: $2.51B
Trailing P/E: 0.00
Forward P/E: 196.08

Financial Highlights

Market Cap: $2.94B
EBITDA: $-64.09M
Book Value: $6.24
Earnings/Share: $-0.35
Profit Margin: -6.77%
Operating Margin: -9.42%
ROA (TTM): -6.40%
ROE (TTM): -5.78%
Revenue (TTM): $642.82M
Revenue/Share (TTM): $5.15
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 4.46x 0.01x 0.24x N/A -0.10x
2024-12-31 4.97x 0.01x 0.23x -48,639.75x -0.07x
2023-12-31 4.69x 0.02x 0.23x -8,040.27x -0.06x
2022-12-31 4.85x 0.01x 0.22x -352.82x -0.07x
2021-12-31 6.77x 0.01x 0.20x -61.10x -0.21x
2020-12-31 6.56x 0.01x 0.20x -50.73x -0.01x
2019-12-31 7.63x 0.07x 0.31x -9.44x -1.42x
2018-12-31 3.28x -0.13x 2.77x -45.98x -0.28x
2017-12-31 3.08x -0.09x 2.49x -22.66x -0.77x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 23, 2026 Adam Taich N/A Sale 8.97K $18.58 $166.63K
Feb 23, 2026 Benjamin J Hindson N/A Sale 7.83K $18.58 $145.41K
Feb 23, 2026 Serge Saxonov N/A Sale 9.63K $18.58 $178.96K
Nov 24, 2025 Adam Taich N/A Sale 11.89K $19.00 $225.87K
Nov 24, 2025 Benjamin J Hindson N/A Sale 8.28K $19.00 $157.38K
Nov 24, 2025 Serge Saxonov N/A Sale 13.26K $19.00 $251.96K
Aug 22, 2025 Adam Taich N/A Sale 22.32K $13.79 $307.72K
Aug 22, 2025 Benjamin J Hindson N/A Sale 7.49K $13.79 $103.23K
Aug 22, 2025 Serge Saxonov N/A Sale 9.35K $13.79 $128.91K
May 22, 2025 Adam Taich N/A Sale 4.04K $8.30 $33.57K
May 22, 2025 Benjamin J Hindson N/A Sale 7.49K $8.30 $62.13K
May 22, 2025 Serge Saxonov N/A Sale 9.34K $8.30 $77.55K

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TXG.US!